PCM
FPRX

Pentwater Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History

Pentwater Capital Management’s Portfolio FPRX Stock Details FPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-1,000,200
Closed -$37.7M – 375
2021
Q1 		$37.7M Buy
+1,000,200
New +$37.7M 0.36% 32